Research

Scientific References

The Slim Govy formulation is backed by peer-reviewed research from leading scientific institutions.

Research sourced from

NIH
Johns Hopkins University
PubMed
New England Journal of Medicine
PLOS ONE
1

Drucker DJ.

Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1.

Cell Metabolism · 2018

2

Wilding JP, et al.

Once-Weekly Semaglutide in Adults with Overweight or Obesity.

New England Journal of Medicine · 2021

3

Nauck MA, Meier JJ.

Incretin hormones: Their role in health and disease.

Diabetes, Obesity and Metabolism · 2018

4

Holst JJ.

The physiology of glucagon-like peptide 1.

Physiological Reviews · 2007

5

Pi-Sunyer X, et al.

A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management.

New England Journal of Medicine · 2015

6

Flint A, et al.

Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans.

Journal of Clinical Investigation · 1998

Questions about our research? Contact us at support@axionlabs.com